CB-5046 analogs (CohBar)

N/A

Report date: 2025/01/26 17:48:41

Base Information

Drug NameCB-5046 analogs (CohBar)
Drug Alias Namemitochondria-based therapeutics (CohBar)CXCR4 inhibitors (CohBar)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsRare DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCohbar Inc
China Registration ClassN/A

Develop Information

Active CompaniesCohbar Inc
Inactive CompaniesN/A
Active IndicationsRare DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A